KLM LABS PVT
GenericsKLM LABS PVT is a generic drug manufacturer focused on Immunology, Gastroenterology.
KLM LABS PVT's Key Drugs
KLM LABS PVT's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
KLM LABS PVT's Recent FDA Approvals
New NDA/BLA approvals for KLM LABS PVT over the last two years — novel drugs only, excluding generics and label supplements.
KLM LABS PVT's Therapeutic Areas
KLM LABS PVT's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Gastroenterology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
KLM LABS PVT's Top Competitors
KLM LABS PVT's closest competitors by therapeutic-area and drug-target overlap include Johnson & Johnson, Bristol-Myers Squibb, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
KLM LABS PVT Pipeline Snapshot
Active clinical trials for KLM LABS PVT across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2026-03-31
- Latest
- 2026-03-31
- Applications
- 1